中信建投 | 医药大健康本周核心推荐

中信建投证券研究
Nov 14, 2025

中信建投证券研究发展部医药大健康研究团队一周核心推荐逻辑精选如下:医药行业周度复盘医疗器械行业周报医药上市公司2025年三季度业绩回顾:结构分化,创新药产业链表现出色《医药行业周度复盘》制药产业链:本周制药行业震荡调整,恒瑞医药在2025年美国肥胖周大会上公布了HRS9531注射液在中国III期临床试验的积极数据;康方生物在2025年SITC会议公布HARMONi-A最终OS数据;百济神州2025...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10